Results 1 to 10 of about 2,702 (143)
Mucolytic Therapy in COPD: Patient Usage and Preferences in Real-World Italian Settings [PDF]
International Journal of COPDSalvatore D’Antonio,1 Alfio Pennisi,2 Mario Cazzola3 1Italian COPD Patients Association, Rome, Italy; 2Department of Respiratory Medicine, Hospital Clinic ‘Casa di Cura Riabilitativa Calaciura’, Catania, Italy; 3Unit of Respiratory Medicine, Department ...
D'Antonio S, Pennisi A, Cazzola M
doaj +2 more sources
Investigation into the Effectiveness of an Herbal Combination (Angocin®Anti-Infekt N) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort Study [PDF]
AntibioticsBackground: The goal of this study was to evaluate whether the medical recommendation of Angocin®Anti-Infekt N (heretofore referenced as Angocin®) on the day of diagnosis of acute bronchitis is negatively associated with the recurrence of acute ...
Nina Kassner +4 more
doaj +2 more sources
Педиатрическая фармакология, 2013 When prescribing mucolytic therapy for bronchopulmonary diseases to infants, it is necessary to consider not only peculiarities of a small child’s respiratory tract, but also action of mucolytic drugs.
I. V. Davydova +2 more
doaj +3 more sources
Approaches to the diagnosis and therapy of cough in therapeutic practice
Лечащий Врач, 2023 Cough is one of the most important symptoms of the pathology of various organs and systems, which occurs in about 30% of the human population. This symptom prevails in patients with various bronchopulmonary pathologies, however, in addition, it can occur
D. S. Sukhanov +2 more
doaj +1 more source
Pharmacodynamic approaches to the use of mucoactive drugs
Лечащий Врач, 2021 Cough is a reflex, protective and adaptive reaction of the body aimed at removing foreign sub-stances and/or pathologically altered tracheobronchial secretions from the respiratory tract.
S. V. Okovity +2 more
doaj +1 more source
Pharmacological approaches to the rational choice of combined mucoactive drugs
Лечащий Врач, 2021 The article analyzes the literature data and considers modern drugs of mucoactive therapy used for cough. The points of application and mechanism of action of the main groups of mucoactive drugs – expectorants, mucokinetics, mucoregulators and mucolytics
S. V. Okovity +3 more
doaj +1 more source
Updated therapies in bronchiectasis [PDF]
Romanian Journal of Medical Practice, 2017 Objective. The aim of this study is to evaluate the constantly updated and integrated treatment strategies for the improvement and the cure of bronchiectasis, with a beneficial effect on the quality of life of patients diagnosed with this disease ...
Gabriela C. OBILIŞTEANU +5 more
doaj +1 more source
Mucolytics for bronchiectasis [PDF]
Cochrane Database of Systematic Reviews, 2014 Bronchiectasis is predominantly an acquired disease process that represents the end stage of a variety of unrelated pulmonary insults. It is defined as persistent irreversible dilatation and distortion of medium-sized bronchi. It has been suggested that with widespread use of high-resolution computed tomography, more bronchiectasis diagnoses are being ...
Wilkinson, M. +5 more
openaire +4 more sources
Лечащий Врач, 2023 In the structure of morbidity in the Russian Federation, respiratory system diseases are in the lead, among which acute respiratory viral infections and bronchitis are make up the majority, as well the leaders in the number of disability cases.
A. L. Vertkin +2 more
doaj +1 more source
Approaches to the treatment of cough in children
Медицинский совет, 2020 Acute respiratory infections (ORI) are one of the most common causes of primary medical care in Pediatrics. The clinical picture of ORI is almost always accompanied by a combination of symptoms such as nasal discharge, nasal congestion, sore throat and ...
A. R. Denisova
doaj +1 more source